Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 8Completed 5Active not recruiting 4Terminated 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Burkitt Lymphoma 1

Interventions

blinatumomab 2Immunotherapy, Adoptive 2pomalidomide 1Specimen Handling 1Interleukin 1 Receptor Antagonist Protein 1Inotuzumab Ozogamicin 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Burkitt Lymphoma × Inotuzumab Ozogamicin × Clear all
NCT07476729 2026-03-17

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

Charite University, Berlin, Germany

Phase 3 Not yet recruiting
750 enrolled
Lymphoid

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡